APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hyperimmune Globulins

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Selected research

Industry Growth & Trends

Global Hyperimmune Globulins Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchHyperimmune Globulins Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hyperimmune Globulins Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Hyperimmune Globulins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hyperimmune Globulins Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Hyperimmune Globulins Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Read the full market overview

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

Report Scope

This report provides a structured, data-driven view of the global Hyperimmune Globulins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hyperimmune Globulins market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hyperimmune Globulins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hyperimmune Globulins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hyperimmune Globulins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hyperimmune Globulins Market by Company

CSL Behring

Grifols

Biotest

Kedrion

CBPO

Emergent (Cangene)

Kamada

CNBG

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

ADMA Biologics

Hyperimmune Globulins Segment by Type

Hepatitis B Immunoglobulins

Rabies Immunoglobulins

Tetanus Immunoglobulins

Rho(D) Immunoglobulins

Other

Hyperimmune Globulins Segment by Application

Government Institutions

Private Sector

Other

Hyperimmune Globulins Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hyperimmune Globulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis B Immunoglobulins Table 2. Major Company of Rabies Immunoglobulins Table 3. Major Company of Tetanus Immunoglobulins Table 4. Major Company of Rho(D) Immunoglobulins Table 5. Major Company of Other Table 6. Global Hyperimmune Globulins Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 8. Global Hyperimmune Globulins Sales Market Share in Volume by Type (2021-2026) Table 9. Global Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 10. Global Hyperimmune Globulins Sales Market Share in Value by Type (2021-2026) Table 11. Global Hyperimmune Globulins Price by Type (2021-2026) & (USD/Unit) Table 12. Global Hyperimmune Globulins Sales by Type (2027-2032) & (K Units) Table 13. Global Hyperimmune Globulins Sales Market Share in Volume by Type (2027-2032) Table 14. Global Hyperimmune Globulins Sales by Type (2027-2032) & (US$ Million) Table 15. Global Hyperimmune Globulins Sales Market Share in Value by Type (2027-2032) Table 16. Global Hyperimmune Globulins Price by Type (2027-2032) & (USD/Unit) Table 17. North America Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 18. North America Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 20. Europe Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 24. Latin America Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Hyperimmune Globulins Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Hyperimmune Globulins Sales by Type (2021-2026) & (US$ Million) Table 27. Hyperimmune Globulins Industry Trends Table 28. Hyperimmune Globulins Industry Drivers Table 29. Hyperimmune Globulins Industry Opportunities and Challenges Table 30. Hyperimmune Globulins Industry Restraints Table 31. Global Hyperimmune Globulins Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Hyperimmune Globulins Revenue Market Share by Company (2021-2026) Table 33. Global Hyperimmune Globulins Sales by Company (2021-2026) & (K Units) Table 34. Global Hyperimmune Globulins Sales Share by Company (2021-2026) Table 35. Global Hyperimmune Globulins Market Price by Company (2021-2026) & (USD/Unit) Table 36. Global Hyperimmune Globulins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Hyperimmune Globulins Major Company Production Sites and Headquarters Table 38. Global Hyperimmune Globulins Company, Product Type & Application Table 39. Global Hyperimmune Globulins Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Hyperimmune Globulins Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Hyperimmune Globulins Sales by Region (2021-2026) & (K Units) Table 44. Global Hyperimmune Globulins Sales Market Share in Volume by Region (2021-2026) Table 45. Global Hyperimmune Globulins Sales by Region (2021-2026) & (US$ Million) Table 46. Global Hyperimmune Globulins Sales Market Share in Value by Region (2021-2026) Table 47. Global Hyperimmune Globulins Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Hyperimmune Globulins Sales by Region (2027-2032) & (K Units) Table 49. Global Hyperimmune Globulins Sales Market Share in Volume by Region (2027-2032) Table 50. Global Hyperimmune Globulins Sales by Region (2027-2032) & (US$ Million) Table 51. Global Hyperimmune Globulins Sales Market Share in Value by Region (2027-2032) Table 52. Global Hyperimmune Globulins Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 53. Global Hyperimmune Globulins Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 55. Global Hyperimmune Globulins Sales Market Share in Volume by Application (2021-2026) Table 56. Global Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 57. Global Hyperimmune Globulins Sales Market Share in Value by Application (2021-2026) Table 58. Global Hyperimmune Globulins Price by Application (2021-2026) & (USD/Unit) Table 59. Global Hyperimmune Globulins Sales by Application (2027-2032) & (K Units) Table 60. Global Hyperimmune Globulins Sales Market Share in Volume by Application (2027-2032) Table 61. Global Hyperimmune Globulins Sales by Application (2027-2032) & (US$ Million) Table 62. Global Hyperimmune Globulins Sales Market Share in Value by Application (2027-2032) Table 63. Global Hyperimmune Globulins Price by Application (2027-2032) & (USD/Unit) Table 64. North America Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 65. North America Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 67. Europe Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 71. Latin America Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Hyperimmune Globulins Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Hyperimmune Globulins Sales by Application (2021-2026) & (US$ Million) Table 74. CSL Behring Company Information Table 75. CSL Behring Business Overview Table 76. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. CSL Behring Hyperimmune Globulins Product Portfolio Table 78. CSL Behring Recent Development Table 79. Grifols Company Information Table 80. Grifols Business Overview Table 81. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Grifols Hyperimmune Globulins Product Portfolio Table 83. Grifols Recent Development Table 84. Biotest Company Information Table 85. Biotest Business Overview Table 86. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Biotest Hyperimmune Globulins Product Portfolio Table 88. Biotest Recent Development Table 89. Kedrion Company Information Table 90. Kedrion Business Overview Table 91. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Kedrion Hyperimmune Globulins Product Portfolio Table 93. Kedrion Recent Development Table 94. CBPO Company Information Table 95. CBPO Business Overview Table 96. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. CBPO Hyperimmune Globulins Product Portfolio Table 98. CBPO Recent Development Table 99. Emergent (Cangene) Company Information Table 100. Emergent (Cangene) Business Overview Table 101. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Emergent (Cangene) Hyperimmune Globulins Product Portfolio Table 103. Emergent (Cangene) Recent Development Table 104. Kamada Company Information Table 105. Kamada Business Overview Table 106. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Kamada Hyperimmune Globulins Product Portfolio Table 108. Kamada Recent Development Table 109. CNBG Company Information Table 110. CNBG Business Overview Table 111. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. CNBG Hyperimmune Globulins Product Portfolio Table 113. CNBG Recent Development Table 114. Hualan Bio Company Information Table 115. Hualan Bio Business Overview Table 116. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Hualan Bio Hyperimmune Globulins Product Portfolio Table 118. Hualan Bio Recent Development Table 119. Shanghai RAAS Company Information Table 120. Shanghai RAAS Business Overview Table 121. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Shanghai RAAS Hyperimmune Globulins Product Portfolio Table 123. Shanghai RAAS Recent Development Table 124. Sichuan Yuanda Shuyang Company Information Table 125. Sichuan Yuanda Shuyang Business Overview Table 126. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolio Table 128. Sichuan Yuanda Shuyang Recent Development Table 129. ADMA Biologics Company Information Table 130. ADMA Biologics Business Overview Table 131. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. ADMA Biologics Hyperimmune Globulins Product Portfolio Table 133. ADMA Biologics Recent Development Table 134. North America Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. North America Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 136. North America Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 137. North America Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 138. North America Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 139. North America Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Hyperimmune Globulins Market Share by Country (2021-2026) Table 142. North America Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 144. Europe Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Europe Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 146. Europe Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 147. Europe Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 148. Europe Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Hyperimmune Globulins Market Share by Country (2021-2026) Table 152. Europe Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 156. Asia-Pacific Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 158. Asia-Pacific Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Hyperimmune Globulins Market Share by Country (2021-2026) Table 162. Asia-Pacific Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 164. Latin America Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Latin America Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 166. Latin America Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 167. Latin America Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 168. Latin America Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Hyperimmune Globulins Market Share by Country (2021-2026) Table 172. Latin America Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Hyperimmune Globulins Sales by Country (2021-2026) & (K Units) Table 176. Middle East and Africa Hyperimmune Globulins Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Hyperimmune Globulins Sales Forecast by Country (2027-2032) & (K Units) Table 178. Middle East and Africa Hyperimmune Globulins Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Hyperimmune Globulins Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Hyperimmune Globulins Market Share by Country (2021-2026) Table 182. Middle East and Africa Hyperimmune Globulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Hyperimmune Globulins Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Hyperimmune Globulins Distributors List Table 187. Hyperimmune Globulins Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Hyperimmune Globulins Image Figure 2. Global Hyperimmune Globulins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hyperimmune Globulins Market Size (2021-2032) & (US$ Million) Figure 4. Global Hyperimmune Globulins Sales (2021-2032) & (K Units) Figure 5. Hepatitis B Immunoglobulins Image Figure 6. Global Hepatitis B Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rabies Immunoglobulins Image Figure 8. Global Rabies Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tetanus Immunoglobulins Image Figure 10. Global Tetanus Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 11. Rho(D) Immunoglobulins Image Figure 12. Global Rho(D) Immunoglobulins Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Hyperimmune Globulins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Hyperimmune Globulins Market Share by Type 2025 VS 2032 Figure 17. North America Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 18. North America Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 19. Europe Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 20. Europe Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 23. Latin America Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Hyperimmune Globulins Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Hyperimmune Globulins Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Hyperimmune Globulins Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Government Institutions Image Figure 30. Global Government Institutions Sales YoY Growth (2021-2032) & (K Units) Figure 31. Private Sector Image Figure 32. Global Private Sector Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Hyperimmune Globulins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Hyperimmune Globulins Market Share by Application 2025 VS 2032 Figure 37. North America Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 38. North America Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 39. Europe Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 40. Europe Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 43. Latin America Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Hyperimmune Globulins Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Hyperimmune Globulins Sales Market Share in Value by Application in 2025 Figure 47. North America Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Hyperimmune Globulins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Hyperimmune Globulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Hyperimmune Globulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Hyperimmune Globulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hyperimmune Globulins Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Hyperimmune Globulins Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Immunoglobulins
  • Rabies Immunoglobulins
  • Tetanus Immunoglobulins
  • Rho(D) Immunoglobulins
  • Other
Applications
  • Government Institutions
  • Private Sector
  • Other
Companies covered
  • CSL Behring
  • Grifols
  • Biotest
  • Kedrion
  • CBPO
  • Emergent (Cangene)
  • Kamada
  • CNBG
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hyperimmune Globulins Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hyperimmune Globulins Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hyperimmune Globulins Market by Type
  6. 1.3.1 Hepatitis B Immunoglobulins
  7. 1.3.2 Rabies Immunoglobulins
  8. 1.3.3 Tetanus Immunoglobulins
  9. 1.3.4 Rho(D) Immunoglobulins
  10. 1.3.5 Other
  11. 1.4 Global Hyperimmune Globulins Market Size by Type
  12. 1.4.1 Global Hyperimmune Globulins Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Hyperimmune Globulins Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Hyperimmune Globulins Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Hyperimmune Globulins Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hyperimmune Globulins Industry Trends
  2. 2.2 Hyperimmune Globulins Industry Drivers
  3. 2.3 Hyperimmune Globulins Industry Opportunities and Challenges
  4. 2.4 Hyperimmune Globulins Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hyperimmune Globulins Revenue (2021-2026)
  2. 3.2 Global Top Players by Hyperimmune Globulins Sales (2021-2026)
  3. 3.3 Global Top Players by Hyperimmune Globulins Price (2021-2026)
  4. 3.4 Global Hyperimmune Globulins Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hyperimmune Globulins Major Company Production Sites & Headquarters
  6. 3.6 Global Hyperimmune Globulins Company, Product Type & Application
  7. 3.7 Global Hyperimmune Globulins Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hyperimmune Globulins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hyperimmune Globulins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hyperimmune Globulins Tier 1, Tier 2, and Tier 3
4 Hyperimmune Globulins Regional Status and Outlook
  1. 4.1 Global Hyperimmune Globulins Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hyperimmune Globulins Historic Market Size by Region
  3. 4.2.1 Global Hyperimmune Globulins Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hyperimmune Globulins Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hyperimmune Globulins Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hyperimmune Globulins Forecasted Market Size by Region
  7. 4.3.1 Global Hyperimmune Globulins Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hyperimmune Globulins Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hyperimmune Globulins Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hyperimmune Globulins by Application
  1. 5.1 Hyperimmune Globulins Market by Application
  2. 5.1.1 Government Institutions
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Hyperimmune Globulins Market Size by Application
  6. 5.2.1 Global Hyperimmune Globulins Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hyperimmune Globulins Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hyperimmune Globulins Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hyperimmune Globulins Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL Behring
  2. 6.1.1 CSL Behring Company Information
  3. 6.1.2 CSL Behring Business Overview
  4. 6.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Behring Hyperimmune Globulins Product Portfolio
  6. 6.1.5 CSL Behring Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Hyperimmune Globulins Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 Biotest
  14. 6.3.1 Biotest Company Information
  15. 6.3.2 Biotest Business Overview
  16. 6.3.3 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biotest Hyperimmune Globulins Product Portfolio
  18. 6.3.5 Biotest Recent Developments
  19. 6.4 Kedrion
  20. 6.4.1 Kedrion Company Information
  21. 6.4.2 Kedrion Business Overview
  22. 6.4.3 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kedrion Hyperimmune Globulins Product Portfolio
  24. 6.4.5 Kedrion Recent Developments
  25. 6.5 CBPO
  26. 6.5.1 CBPO Company Information
  27. 6.5.2 CBPO Business Overview
  28. 6.5.3 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CBPO Hyperimmune Globulins Product Portfolio
  30. 6.5.5 CBPO Recent Developments
  31. 6.6 Emergent (Cangene)
  32. 6.6.1 Emergent (Cangene) Company Information
  33. 6.6.2 Emergent (Cangene) Business Overview
  34. 6.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Emergent (Cangene) Hyperimmune Globulins Product Portfolio
  36. 6.6.5 Emergent (Cangene) Recent Developments
  37. 6.7 Kamada
  38. 6.7.1 Kamada Company Information
  39. 6.7.2 Kamada Business Overview
  40. 6.7.3 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kamada Hyperimmune Globulins Product Portfolio
  42. 6.7.5 Kamada Recent Developments
  43. 6.8 CNBG
  44. 6.8.1 CNBG Company Information
  45. 6.8.2 CNBG Business Overview
  46. 6.8.3 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CNBG Hyperimmune Globulins Product Portfolio
  48. 6.8.5 CNBG Recent Developments
  49. 6.9 Hualan Bio
  50. 6.9.1 Hualan Bio Company Information
  51. 6.9.2 Hualan Bio Business Overview
  52. 6.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hualan Bio Hyperimmune Globulins Product Portfolio
  54. 6.9.5 Hualan Bio Recent Developments
  55. 6.10 Shanghai RAAS
  56. 6.10.1 Shanghai RAAS Company Information
  57. 6.10.2 Shanghai RAAS Business Overview
  58. 6.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanghai RAAS Hyperimmune Globulins Product Portfolio
  60. 6.10.5 Shanghai RAAS Recent Developments
  61. 6.11 Sichuan Yuanda Shuyang
  62. 6.11.1 Sichuan Yuanda Shuyang Company Information
  63. 6.11.2 Sichuan Yuanda Shuyang Business Overview
  64. 6.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Portfolio
  66. 6.11.5 Sichuan Yuanda Shuyang Recent Developments
  67. 6.12 ADMA Biologics
  68. 6.12.1 ADMA Biologics Company Information
  69. 6.12.2 ADMA Biologics Business Overview
  70. 6.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ADMA Biologics Hyperimmune Globulins Product Portfolio
  72. 6.12.5 ADMA Biologics Recent Developments
7 North America by Country
  1. 7.1 North America Hyperimmune Globulins Sales by Country
  2. 7.1.1 North America Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hyperimmune Globulins Sales by Country (2021-2026)
  4. 7.1.3 North America Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hyperimmune Globulins Market Size by Country
  6. 7.2.1 North America Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 7.2.3 North America Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hyperimmune Globulins Sales by Country
  2. 8.1.1 Europe Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hyperimmune Globulins Sales by Country (2021-2026)
  4. 8.1.3 Europe Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hyperimmune Globulins Market Size by Country
  6. 8.2.1 Europe Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hyperimmune Globulins Sales by Country
  2. 9.1.1 Asia-Pacific Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hyperimmune Globulins Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hyperimmune Globulins Market Size by Country
  6. 9.2.1 Asia-Pacific Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hyperimmune Globulins Sales by Country
  2. 10.1.1 South America Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hyperimmune Globulins Sales by Country (2021-2026)
  4. 10.1.3 South America Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hyperimmune Globulins Market Size by Country
  6. 10.2.1 South America Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 10.2.3 South America Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hyperimmune Globulins Sales by Country
  2. 11.1.1 Middle East and Africa Hyperimmune Globulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hyperimmune Globulins Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hyperimmune Globulins Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hyperimmune Globulins Market Size by Country
  6. 11.2.1 Middle East and Africa Hyperimmune Globulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hyperimmune Globulins Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hyperimmune Globulins Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hyperimmune Globulins Value Chain Analysis
  2. 12.1.1 Hyperimmune Globulins Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hyperimmune Globulins Production Mode & Process
  7. 12.2 Hyperimmune Globulins Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hyperimmune Globulins Distributors
  10. 12.2.3 Hyperimmune Globulins Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst